期刊文献+

β-磷酸三钙煅烧骨负载抗生素治疗慢性骨髓炎的实验研究 被引量:4

Beta-tricalcium phosphate sintered bone/antibiotics drug delivery systems for treating chronic osteomyelitis
下载PDF
导出
摘要 背景:可生物降解抗生素载药系统具有载体材料可降解、抗生素释放完全、局部药物浓度高、抗感染效果好、全身不良反应小等优点。目的:观察负载庆大霉素的β-磷酸三钙煅烧骨可生物降解抗生素释放系统治疗慢性骨髓炎的效果。方法:取48只新西兰大白兔制作慢性骨髓炎模型,随机分为实验组与对照组,实验组骨缺损部位植入复合庆大霉素的β-磷酸三钙煅烧骨可降解抗生素释放系统,对照组骨缺损处植入β-磷酸三钙煅烧骨颗粒。结果与结论:实验组动物全身状态、伤口愈合情况、静脉血中白细胞及C-反应蛋白变化情况均好于对照组。实验组局部抗生素药物浓度在术后第1天内爆发释放,达到较高浓度,术后4周时仍能够维持在有效抑菌浓度10倍以上,但在保持局部组织药物浓度较高同时全身药物浓度较低,在术后3周基本在周围静脉血中不再能够检测到抗生素。表明负载庆大霉素的β-磷酸三钙煅烧骨可生物降解抗生素释放系统可较好治疗慢性骨髓炎。 BACKGROUND: Biological degradation antibiotics drug delivery systems possess some advantages, such as the biological degradation of the carrying materials, complete delivery of the antibiotics, higher density of part drug, better effectiveness of anti-infection and fewer systemic adverse reactions. OBJECTIVE: To observe the effectiveness of the antibiotics drug delivery systems of the 13-tricalcium phosphate sintered bone loading gentamycin for treating chronic osteomyelitis. METHODS: Forty-eight New Zealand white rabbits were selected to make the model of chronic osteomyelitis, and then randomly divided into experimental group and control group. The antibiotics drug delivery systems of the ^-tricalcium phosphate sintered bone loading gentamycin was implanted into the experimental group, and the particles of 13-tricalcium phosphate sintered bone were implanted into the defect site of the control group. RESULTS AND CONCLUSION: The general reactions, wound healing, changing of the white blood cells and C-reactive protein in the venous blood of the experimental group were better than those of the control group. The antibiotics drug concentration in the experimental group could achieve burst release and reach peak at the 1st day postoperation, then maintained a higher concentration that was 10 times higher than its effective bacteriostasis concentration within 4 weeks postoperation; but when there was a higher antibiotics drug concentration in the local tissue, the general drug concentration was lowered. At 3 weeks after operation, the antibiotics drug concentration in the venous blood could not be observed. All of above showed that the antibiotics drug delivery systems of the 13-tricalcium phosphate sintered bone loading gentamycin could treat chronic osteomyelitis better.
出处 《中国组织工程研究》 CAS CSCD 2012年第51期9518-9522,共5页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献12

二级参考文献32

共引文献37

同被引文献71

  • 1孙忠河.抗生素骨水泥治疗感染性骨缺损疗效观察[J].中国药物经济学,2012(6):143.
  • 2ShiHui Chen,Ming Lei,Ge Zhang,et al.PLGA/TCP/icaritin scaffoldsenhanceangiogenesisinhonedefecthealing[J].第六届国际骨质疏松及骨矿盐疾病学术会议论文集,2012.
  • 3Chen Lijia,Bu Hong. Journal of Wuhan University of Technology(Materials Science Edition)[J].Tissue Response of an Osteoinductive Bioceramic in Bone Defect Rabbit Model,2010.
  • 4余建平,苏云星,刘芳.胶原-明胶海绵作为金葡液载体修复骨缺损的实验研究[J].山西医药杂志(上半月),2008,37(1):26-28. 被引量:10
  • 5Howe BM, Wenger DE, Mandrekar J, et al. T1 -weighted MRI Ima- ging Features of Pathologically Proven Non - pedal Osteomyelitis [ J ]. Acad Radiol, 2013,20( 1 ) :108 - 114.
  • 6Tocco MP, Ballardini M, Masala M, et al. Post - stemotomy chronic osteomyelitis : ls sternal resection always necessary [ J ] ? Eur J Cardio- thorac Surg, 2013,43(4) :715 -721.
  • 7Koort JK,Suokas E,Veiranto M,et al.In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment[J].J Biomed Mater Res A,2006,78(3):532-540.
  • 8SemdéR,Gondi RF,SombiéBC,et al.Effect of hydroxyapatite on the physicochemical characteristics of a gentamicin-loaded monoolein gel intended to treat chronic osteomyelitis[J].J Adv Pharm Tech Res,2012,3(2):100-105.
  • 9Shirtliff ME,Calhoun JH,Mader JT.Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite[J].Clin Orthop Relat Res,2002(401):239-247.
  • 10Zhou TH,Su M,Shang BC,et al.Nano-hydroxyapatite/β-tricalcium phosphate ceramics scaffolds loaded with cationic liposomal ceftazidime:preparation,release characteristics in vitro and inhibition to Staphylococcus aureus biofilms[J].Drug Dev Ind Pharm,2012,38(11):1298-1304.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部